Aquestive Therapeutics, Inc.AQSTNASDAQ
LOADING
|||
Cash Flow Performance
Trending lower, above historical average, strong compound growth.
Left:
||||
Free cash flow yield
Latest
-11.63%
↑ 29% above average
Average (8y)
-16.42%
Historical baseline
Range
High:1.17%
Low:-41.25%
CAGR
+22.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -11.63% | -95.2% |
| 2023 | -5.96% | +78.7% |
| 2022 | -28.01% | -22.4% |
| 2021 | -22.88% | +10.4% |
| 2020 | -25.54% | +38.1% |
| 2019 | -41.25% | -263.5% |
| 2018 | -11.35% | -1069.7% |
| 2017 | 1.17% | +150.3% |
| 2016 | -2.33% | - |